LS Investment Advisors LLC decreased its stake in AmerisourceBergen Corp. (NYSE:ABC) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,456 shares of the company’s stock after selling 140 shares during the quarter. LS Investment Advisors LLC’s holdings in AmerisourceBergen were worth $704,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of ABC. FMR LLC raised its holdings in shares of AmerisourceBergen by 8.2% during the second quarter. FMR LLC now owns 4,460,016 shares of the company’s stock valued at $380,305,000 after acquiring an additional 338,690 shares during the period. Atria Investments LLC increased its stake in AmerisourceBergen by 11.5% in the 3rd quarter. Atria Investments LLC now owns 14,613 shares of the company’s stock valued at $1,348,000 after buying an additional 1,502 shares during the period. Lourd Capital LLC acquired a new position in AmerisourceBergen in the 3rd quarter valued at approximately $282,000. DNB Asset Management AS increased its stake in AmerisourceBergen by 11.8% in the 3rd quarter. DNB Asset Management AS now owns 23,530 shares of the company’s stock valued at $2,170,000 after buying an additional 2,482 shares during the period. Finally, BLB&B Advisors LLC acquired a new position in AmerisourceBergen in the 3rd quarter valued at approximately $208,000. Institutional investors and hedge funds own 66.10% of the company’s stock.
ABC stock opened at $84.31 on Friday. The company has a quick ratio of 0.53, a current ratio of 0.94 and a debt-to-equity ratio of 1.43. The company has a market capitalization of $17.80 billion, a price-to-earnings ratio of 12.99, a price-to-earnings-growth ratio of 1.55 and a beta of 1.12. AmerisourceBergen Corp. has a 12 month low of $69.36 and a 12 month high of $102.00.
AmerisourceBergen (NYSE:ABC) last posted its earnings results on Thursday, January 31st. The company reported $1.60 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.50 by $0.10. The company had revenue of $45.39 billion during the quarter, compared to the consensus estimate of $43.52 billion. AmerisourceBergen had a net margin of 0.69% and a return on equity of 44.53%. On average, equities research analysts predict that AmerisourceBergen Corp. will post 6.75 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 4th. Shareholders of record on Tuesday, February 19th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.90%. The ex-dividend date of this dividend is Friday, February 15th. AmerisourceBergen’s dividend payout ratio is 24.65%.
Several research firms have weighed in on ABC. ValuEngine upgraded shares of AmerisourceBergen from a “sell” rating to a “hold” rating in a research note on Thursday, January 31st. UBS Group began coverage on shares of AmerisourceBergen in a research note on Thursday, January 17th. They issued a “buy” rating and a $89.00 price objective on the stock. TheStreet lowered shares of AmerisourceBergen from a “b-” rating to a “c+” rating in a research note on Tuesday, January 8th. Zacks Investment Research upgraded shares of AmerisourceBergen from a “sell” rating to a “hold” rating in a research note on Monday, January 7th. Finally, Barclays reiterated a “hold” rating and issued a $84.00 price objective on shares of AmerisourceBergen in a research note on Sunday, January 6th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $96.00.
In other AmerisourceBergen news, CEO Steven H. Collis sold 21,350 shares of the business’s stock in a transaction that occurred on Wednesday, January 2nd. The shares were sold at an average price of $73.96, for a total value of $1,579,046.00. Following the completion of the sale, the chief executive officer now directly owns 155,929 shares of the company’s stock, valued at $11,532,508.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Dale Danilewitz sold 5,703 shares of the business’s stock in a transaction that occurred on Thursday, February 7th. The stock was sold at an average price of $86.80, for a total transaction of $495,020.40. Following the completion of the sale, the insider now directly owns 8,960 shares of the company’s stock, valued at $777,728. The disclosure for this sale can be found here. Insiders sold 143,152 shares of company stock valued at $12,095,954 over the last three months. Insiders own 27.80% of the company’s stock.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
See Also: Index Funds
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.